TY  - GEN
AU  - Snedecor,Sonya J
AU  - Carter,John A
AU  - Kaura,Satyin
AU  - Botteman,Marc F
TI  - Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a cost-effectiveness analysis
SN  - 1941-837X
PY  - 2013///0522
KW  - Antibodies, Monoclonal, Humanized
KW  - economics
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Denosumab
KW  - Diphosphonates
KW  - Disease Progression
KW  - Health Expenditures
KW  - statistics & numerical data
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Markov Chains
KW  - Models, Econometric
KW  - Prostatic Neoplasms
KW  - pathology
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
KW  - Survival Analysis
KW  - United States
KW  - Zoledronic Acid
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.3111/13696998.2012.719054
ER  -